|
OMIM |
Link |
Information gain |
01 |
|
IGAD1
|
[NCBI]
|
0.00363384
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.0018915
|
|
|
SLE
|
[NCBI]
|
0.00144632
|
|
|
enteropathy, protein-losing
|
[NCBI]
|
0.00129874
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.000933827
|
|
|
RA
|
[NCBI]
|
0.000546105
|
|
|
MBP
|
[NCBI]
|
0.000538265
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000447941
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000396033
|
|
|
CVID
|
[NCBI]
|
0.000376282
|
|
|
ragweed sensitivity
|
[NCBI]
|
0.000234692
|
|
|
IL2
|
[NCBI]
|
0.000234508
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.000217868
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000166224
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
0.000156407
|
|
|
CEACAM5
|
[NCBI]
|
0.00015226
|
|
|
AD
|
[NCBI]
|
0.000150684
|
|
|
MG
|
[NCBI]
|
0.000141586
|
|
|
BCGF
|
[NCBI]
|
0.00014028
|
|
|
CRC
|
[NCBI]
|
0.000121138
|
|
|
IS
|
[NCBI]
|
0.000116951
|
|
|
lymphokine deficiency
|
[NCBI]
|
0.000105849
|
|
|
IPD2
|
[NCBI]
|
0.000105849
|
|
|
cd8 deficiency, familial
|
[NCBI]
|
0.000105849
|
|
|
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant
|
[NCBI]
|
0.000101052
|
|
|
TG
|
[NCBI]
|
9.78183e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
8.81538e-05
|
|
|
ADA
|
[NCBI]
|
7.94129e-05
|
|
|
hypercalcemia, idiopathic, of infancy
|
[NCBI]
|
7.81767e-05
|
|
|
IPD1
|
[NCBI]
|
7.81767e-05
|
|
|
secretory component deficiency
|
[NCBI]
|
7.81767e-05
|
|
|
buerger disease
|
[NCBI]
|
7.81767e-05
|
|
|
t-cell subgroups, non-hla-linked
|
[NCBI]
|
7.81767e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
7.73637e-05
|
|
|
VEGF
|
[NCBI]
|
7.51837e-05
|
|
|
EGF
|
[NCBI]
|
7.32183e-05
|
|
|
ICOS
|
[NCBI]
|
6.89493e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
6.77954e-05
|
|
|
surface antigen, glycoprotein 75
|
[NCBI]
|
6.77954e-05
|
|
|
TNF
|
[NCBI]
|
6.56927e-05
|
|
|
HIGM1
|
[NCBI]
|
6.15152e-05
|
|
|
XLP1
|
[NCBI]
|
6.15152e-05
|
|
|
CD40
|
[NCBI]
|
6.14992e-05
|
|
|
IGAD2
|
[NCBI]
|
6.10895e-05
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
6.10895e-05
|
|
|
tuftsin deficiency
|
[NCBI]
|
6.10895e-05
|
|
|
WAS
|
[NCBI]
|
5.79705e-05
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
5.61291e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
5.61291e-05
|
|
|
whim syndrome
|
[NCBI]
|
5.21969e-05
|
|
|
BTK
|
[NCBI]
|
5.06743e-05
|
|
|
CF
|
[NCBI]
|
4.91107e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
4.89439e-05
|
|
|
LYN
|
[NCBI]
|
4.88724e-05
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
4.61738e-05
|
|
|
SLEB1
|
[NCBI]
|
4.61738e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
4.50065e-05
|
|
|
TNFSF13
|
[NCBI]
|
4.40532e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
4.37648e-05
|
|
|
SH2D1A
|
[NCBI]
|
4.26256e-05
|
|
|
CLDN11
|
[NCBI]
|
3.7275e-05
|
|
|
MB
|
[NCBI]
|
3.70876e-05
|
|
|
NUDCD1
|
[NCBI]
|
3.68577e-05
|
|
|
IL17A
|
[NCBI]
|
3.65649e-05
|
|
|
heart block, congenital
|
[NCBI]
|
3.64392e-05
|
|
|
CJD
|
[NCBI]
|
3.45638e-05
|
|
|
CDG2C
|
[NCBI]
|
3.3668e-05
|
|
|
CYP1A1
|
[NCBI]
|
3.26228e-05
|
|
|
TPO
|
[NCBI]
|
3.17845e-05
|
|
|
LDHB
|
[NCBI]
|
3.16143e-05
|
|
|
DGS
|
[NCBI]
|
3.1414e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
3.02047e-05
|
|
|
TNFSF8
|
[NCBI]
|
2.99593e-05
|
|
|
ZP2
|
[NCBI]
|
2.86222e-05
|
|
|
FCN3
|
[NCBI]
|
2.86222e-05
|
|
|
phosphoinositide 3-kinase adaptor protein 1
|
[NCBI]
|
2.86222e-05
|
|
|
TLR9
|
[NCBI]
|
2.84221e-05
|
|
|
SLAMF1
|
[NCBI]
|
2.78619e-05
|
|
|
TNFSF13B
|
[NCBI]
|
2.78619e-05
|
|
|
IL13
|
[NCBI]
|
2.78619e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
2.66563e-05
|
|
|
PCNA
|
[NCBI]
|
2.61191e-05
|
|
|
CTLA4
|
[NCBI]
|
2.5832e-05
|
|
|
HRH2
|
[NCBI]
|
2.55213e-05
|
|
|
PADI3
|
[NCBI]
|
2.55213e-05
|
|
|
CD33
|
[NCBI]
|
2.55213e-05
|
|
|
IHG
|
[NCBI]
|
2.55213e-05
|
|
|
PF4
|
[NCBI]
|
2.52722e-05
|
|
|
TH
|
[NCBI]
|
2.46955e-05
|
|
|
AVP
|
[NCBI]
|
2.44838e-05
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
2.35118e-05
|
|
|
BEST3
|
[NCBI]
|
2.35118e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.34754e-05
|
|
|
SPDA1
|
[NCBI]
|
2.21661e-05
|
|
|
BEST2
|
[NCBI]
|
2.20207e-05
|
|
|
BEST4
|
[NCBI]
|
2.20207e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.14392e-05
|
|
|
graves disease
|
[NCBI]
|
2.09631e-05
|
|
|
HELLS
|
[NCBI]
|
2.08349e-05
|
|
|
CTCFL
|
[NCBI]
|
2.08349e-05
|
|
|
SLC29A4
|
[NCBI]
|
2.08349e-05
|
|
|
RP
|
[NCBI]
|
2.0518e-05
|
|
|
IL10
|
[NCBI]
|
2.00491e-05
|
|
|
CD22
|
[NCBI]
|
1.98508e-05
|
|
|
CD7
|
[NCBI]
|
1.98508e-05
|
|
|
CD83
|
[NCBI]
|
1.98508e-05
|
|
|
TICAM1
|
[NCBI]
|
1.98508e-05
|
|
|
MAG
|
[NCBI]
|
1.97447e-05
|
|
|
AFP
|
[NCBI]
|
1.91729e-05
|
|
|
FCGRT
|
[NCBI]
|
1.90101e-05
|
|
|
TNFSF7
|
[NCBI]
|
1.90101e-05
|
|
|
ERV1
|
[NCBI]
|
1.82766e-05
|
|
|
CCR7
|
[NCBI]
|
1.82766e-05
|
|
|
BCL10
|
[NCBI]
|
1.82766e-05
|
|
|
CARD11
|
[NCBI]
|
1.82766e-05
|
|
|
HRH1
|
[NCBI]
|
1.82766e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
1.78647e-05
|
|
|
NFAT5
|
[NCBI]
|
1.76263e-05
|
|
|
IRAK4
|
[NCBI]
|
1.76263e-05
|
|
|
EXO1
|
[NCBI]
|
1.76263e-05
|
|
|
MALT1
|
[NCBI]
|
1.76263e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
1.76263e-05
|
|
|
CD19
|
[NCBI]
|
1.76263e-05
|
|
|
HLA-A
|
[NCBI]
|
1.74924e-05
|
|
|
CD38
|
[NCBI]
|
1.70425e-05
|
|
|
VAV1
|
[NCBI]
|
1.70425e-05
|
|
|
TNFSF4
|
[NCBI]
|
1.70425e-05
|
|
|
RFX5
|
[NCBI]
|
1.65131e-05
|
|
|
FA
|
[NCBI]
|
1.63892e-05
|
|
|
FCGR2B
|
[NCBI]
|
1.60288e-05
|
|
|
PRKCZ
|
[NCBI]
|
1.60288e-05
|
|
|
XBP1
|
[NCBI]
|
1.60288e-05
|
|
|
MOG
|
[NCBI]
|
1.60288e-05
|
|
|
ACHE
|
[NCBI]
|
1.59971e-05
|
|
|
PIK3R1
|
[NCBI]
|
1.47849e-05
|
|
|
LAD
|
[NCBI]
|
1.46078e-05
|
|
|
CXCL13
|
[NCBI]
|
1.4425e-05
|
|
|
LRAT
|
[NCBI]
|
1.4425e-05
|
|
|
BEST1
|
[NCBI]
|
1.4425e-05
|
|
|
IL7R
|
[NCBI]
|
1.40869e-05
|
|
|
THY1
|
[NCBI]
|
1.40869e-05
|
|
|
AMFR
|
[NCBI]
|
1.40869e-05
|
|
|
IL6ST
|
[NCBI]
|
1.37684e-05
|
|
|
APOE
|
[NCBI]
|
1.35422e-05
|
|
|
IL9
|
[NCBI]
|
1.34672e-05
|
|
|
MMP12
|
[NCBI]
|
1.34672e-05
|
|
|
SN
|
[NCBI]
|
1.31818e-05
|
|
|
MPL
|
[NCBI]
|
1.26521e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
1.26521e-05
|
|
|
GNRH1
|
[NCBI]
|
1.23235e-05
|
|
|
MMP1
|
[NCBI]
|
1.19437e-05
|
|
|
TLR7
|
[NCBI]
|
1.1727e-05
|
|
|
BMP15
|
[NCBI]
|
1.1727e-05
|
|
|
CD44
|
[NCBI]
|
1.15187e-05
|
|
|
AHSG
|
[NCBI]
|
1.15187e-05
|
|
|
MYD88
|
[NCBI]
|
1.15187e-05
|
|
|
CD8A
|
[NCBI]
|
1.13183e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.13183e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
1.11253e-05
|
|
|
PTX3
|
[NCBI]
|
1.09391e-05
|
|
|
AHR
|
[NCBI]
|
1.08512e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.08415e-05
|
|
|
CD40LG
|
[NCBI]
|
1.07593e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.00965e-05
|
|
|
IKBKG
|
[NCBI]
|
1.00965e-05
|
|
|
LPL
|
[NCBI]
|
1.00143e-05
|
|
|
CYP2A6
|
[NCBI]
|
9.94336e-06
|
|
|
IGKC
|
[NCBI]
|
9.94336e-06
|
|
|
ICAM1
|
[NCBI]
|
9.94336e-06
|
|
|
PSCA
|
[NCBI]
|
9.65024e-06
|
|
|
RHCE
|
[NCBI]
|
9.37319e-06
|
|
|
NOD2
|
[NCBI]
|
9.37319e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
9.06659e-06
|
|
|
TRAF2
|
[NCBI]
|
8.98443e-06
|
|
|
ZNF145
|
[NCBI]
|
8.62405e-06
|
|
|
C4A
|
[NCBI]
|
8.62405e-06
|
|
|
menkes disease
|
[NCBI]
|
8.44743e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
8.44743e-06
|
|
|
DMPK
|
[NCBI]
|
8.39777e-06
|
|
|
CTSC
|
[NCBI]
|
8.39777e-06
|
|
|
NP
|
[NCBI]
|
8.07709e-06
|
|
|
DSG3
|
[NCBI]
|
7.97481e-06
|
|
|
IGHG1
|
[NCBI]
|
7.87468e-06
|
|
|
IBD1
|
[NCBI]
|
7.86911e-06
|
|
|
NPPA
|
[NCBI]
|
7.80641e-06
|
|
|
FXN
|
[NCBI]
|
7.77664e-06
|
|
|
ITGB2
|
[NCBI]
|
7.68059e-06
|
|
|
A2M
|
[NCBI]
|
7.49424e-06
|
|
|
C3
|
[NCBI]
|
7.49424e-06
|
|
|
PSEN2
|
[NCBI]
|
7.40379e-06
|
|
|
ACPP
|
[NCBI]
|
7.15e-06
|
|
|
PSORS1
|
[NCBI]
|
6.82157e-06
|
|
|
DNTT
|
[NCBI]
|
6.8163e-06
|
|
|
JAK3
|
[NCBI]
|
6.73829e-06
|
|
|
F3
|
[NCBI]
|
6.27758e-06
|
|
|
PI
|
[NCBI]
|
6.05504e-06
|
|
|
CCK
|
[NCBI]
|
5.90549e-06
|
|
|
TNFSF10
|
[NCBI]
|
5.74838e-06
|
|
|
NGFB
|
[NCBI]
|
5.71614e-06
|
|
|
IDUA
|
[NCBI]
|
5.7102e-06
|
|
|
HRG
|
[NCBI]
|
5.64978e-06
|
|
|
STAT6
|
[NCBI]
|
5.53154e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
5.21776e-06
|
|
|
APS1
|
[NCBI]
|
4.96366e-06
|
|
|
IL4
|
[NCBI]
|
4.6011e-06
|
|
|
TYR
|
[NCBI]
|
4.51041e-06
|
|
|
FFI
|
[NCBI]
|
4.48575e-06
|
|
|
IFNA1
|
[NCBI]
|
4.12813e-06
|
|
|
PLAUR
|
[NCBI]
|
4.00933e-06
|
|
|
LPO
|
[NCBI]
|
3.78338e-06
|
|
|
von willebrand disease
|
[NCBI]
|
3.53774e-06
|
|
|
GFAP
|
[NCBI]
|
3.20714e-06
|
|
|
RNASE3
|
[NCBI]
|
3.18425e-06
|
|
|
EGFR
|
[NCBI]
|
2.81503e-06
|
|
|
EV
|
[NCBI]
|
2.75859e-06
|
|
|
MPO
|
[NCBI]
|
2.57851e-06
|
|
|
CD
|
[NCBI]
|
2.57799e-06
|
|
|
temporal arteritis
|
[NCBI]
|
2.55697e-06
|
|
|
HP
|
[NCBI]
|
2.55001e-06
|
|
|
PRL
|
[NCBI]
|
2.45588e-06
|
|
|
PSEN1
|
[NCBI]
|
2.42192e-06
|
|
|
SHH
|
[NCBI]
|
1.76322e-06
|
|
|
TLR4
|
[NCBI]
|
1.68866e-06
|
|
|
VIP
|
[NCBI]
|
1.59981e-06
|
|
|
COMP
|
[NCBI]
|
1.59892e-06
|
|
|
AT
|
[NCBI]
|
1.36359e-06
|
|
|
TLR2
|
[NCBI]
|
1.34748e-06
|
|
|
SDC2
|
[NCBI]
|
1.12879e-06
|
|
|
BCR
|
[NCBI]
|
1.11685e-06
|
|
|
AKR1B1
|
[NCBI]
|
1.07005e-06
|
|
|
GAPDH
|
[NCBI]
|
9.83331e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
8.24038e-07
|
|
|
ADM
|
[NCBI]
|
8.19283e-07
|
|
|
GHR
|
[NCBI]
|
8.19283e-07
|
|
|
AMH
|
[NCBI]
|
8.09874e-07
|
|
|
DHFR
|
[NCBI]
|
7.79845e-07
|
|
|
POMC
|
[NCBI]
|
7.05784e-07
|
|
|
CHS
|
[NCBI]
|
6.80231e-07
|
|
|
PTH
|
[NCBI]
|
6.79964e-07
|
|
|
XDH
|
[NCBI]
|
4.78852e-07
|
|
|
PTHLH
|
[NCBI]
|
4.37573e-07
|
|
|
INS
|
[NCBI]
|
3.75902e-07
|
|
|
WBS
|
[NCBI]
|
3.36106e-07
|
|
|
GJA1
|
[NCBI]
|
3.02774e-07
|
|
|
CHAT
|
[NCBI]
|
2.66069e-07
|
|
|
OSM
|
[NCBI]
|
2.22701e-07
|
|
|
ACP5
|
[NCBI]
|
1.29316e-07
|
|
|
GHRH
|
[NCBI]
|
1.26091e-07
|
|
|
DMD
|
[NCBI]
|
1.20858e-07
|
|
|
KLK3
|
[NCBI]
|
7.22099e-08
|
|
|
MUC1
|
[NCBI]
|
7.21229e-08
|
|
|
EPO
|
[NCBI]
|
3.96467e-08
|
|
|
TNFSF6
|
[NCBI]
|
3.73344e-08
|
|
|
SPP1
|
[NCBI]
|
3.57374e-08
|
|
|
CRH
|
[NCBI]
|
3.44166e-08
|
|
|
CTGF
|
[NCBI]
|
4.90118e-09
|
|